IPS IPSOS

Success of the "Ipsos Partnership 2024" operation

Success of the "Ipsos Partnership 2024" operation

Success of the "Ipsos Partnership 2024" operation

Paris, 11 June 2024 – Ipsos Partners is an investment entity established in 2016 (see press release of 14 November 2016), dedicated to Ipsos’ executives and senior managers. As of December 31, 2023, Ipsos Partners held a 19% stake in DT & Partners, alongside Didier Truchot, Founder and Chairman of the Ipsos group, who owns 81%.

DT & Partners is the Ipsos SA shareholder of reference, holding 11.2% of the capital and 19.0% of the voting rights as of December 31, 2023.

Through the "Ipsos Partnership 2024" initiative, nearly 330 executives globally opted to invest in the structure, for a total of approximately 18 million euros. The capital raised will allow Ipsos Partners to buy back shares from managers who have left the company since 2018 and strengthen its stake in DT & Partners.

Following these operations, Ipsos Partners will hold 21% of DT & Partners' capital. DT & Partners, which has also acquired Ipsos shares on the market, will now hold 11.4% of Ipsos SA's capital and 19.2% of its voting rights (and DT & Partners, Didier Truchot, and Laurence Stoclet acting in concert, as already communicated, will hold 12.3% of the capital and 20.7% of the listed company's voting rights).

Ipsos aims to strengthen its position as a global leader in its areas of expertise and specialisation, independent from any other external influence. To achieve this, Ipsos needs stable and motivated professional shareholders, determined to act together, alongside the company's other shareholders.

Didier Truchot, Chairman of both Ipsos and Ipsos Partners, and Ben Page, Chief Executive Officer of Ipsos and a member of Ipsos Partners’ Supervisory Board, welcome the operation's success and thank the executives who invested for their trust.

ABOUT IPSOS

Ipsos is one of the largest market research and polling companies globally, operating

in 90 markets and employing nearly 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

“Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices, STOXX Europe 600 and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

35 rue du Val de Marne

75 628 Paris, Cedex 13 France

Tel. 00

IPSOS

Company with a share capital of 10,800,806.25 euros

Registered office: 35, rue du Val de Marne 75013 Paris

304 555 634 RCS PARIS

Attachment



EN
11/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IPSOS

 PRESS RELEASE

Ipsos strengthens its expertise in Germany with the acquisition of InM...

Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division Paris, 7 July 2025 - , one of the world's leading market research companies, announces the acquisition of InMoment’s Healthcare division in Germany, enabling to bolster its expertise in this sector and generate further growth opportunities in the country. Ben Page, CEO of Ipsos, stated: “We are pleased to welcome the experienced InMoment German Healthcare team to Ipsos, adding a new competence ce...

 PRESS RELEASE

Ipsos renforce son expertise en Allemagne avec l'acquisition de la div...

Ipsos renforce son expertise en Allemagne avec l'acquisition de la division Santé d'InMoment Ipsos renforce son expertise en Allemagne avec l'acquisition de la division Santé d'InMoment Paris, 7 juillet 2025 - , l’une des principales sociétés mondiales d’études de marché, annonce l'acquisition de la division Santé d'InMoment en Allemagne, lui permettant de renforcer son expertise dans ce secteur et de générer de nouvelles opportunités de croissance dans le pays. Ben Page, Directeur Général d’Ipsos, a déclaré : « Nous sommes heureux d'accueillir l'équipe allemande expérimentée d'InMoment ...

 PRESS RELEASE

Ipsos Strengthens Its Board of Directors

Ipsos Strengthens Its Board of Directors Ipsos Strengthens Its Board of Directors Paris, June 30, 2025 – Ipsos announces the appointment of three new members to its Board of Directors: Ms. Armelle Carminati-Rabasse, Mr. Lionel Chaine, and Ms. Anne-Marie Couderc. The appointments of Mr. Chaine, as the permanent representative of Bpifrance Investissement, and Ms. Carminati-Rabasse follow the votes held at the Company’s Annual General Meeting on May 21, 2025.The Board of Directors, meeting on June 20, 2025, decided to co-opt Ms. Anne-Marie Couderc to replace Ms. Florence Parly, who stepped d...

 PRESS RELEASE

Ipsos renforce son Conseil d’administration

Ipsos renforce son Conseil d’administration Ipsos renforce son Conseil d’administration Paris, le 30 juin 2025 - Ipsos annonce la nomination de trois nouveaux administrateurs au sein de son Conseil : Mme Armelle Carminati-Rabasse, M. Lionel Chaine et Mme Anne-Marie Couderc. La désignation de M. Chaine, en tant que représentant permanent de Bpifrance investissement, et de de Mme Carminati-Rabasse fait suite au vote de l'Assemblée générale de la société le 21 mai 2025. Le Conseil d’administration, réuni le 20 juin 2025, a décidé de coopter Mme Anne-Marie Couderc, en remplacement de Mme Flo...

 PRESS RELEASE

Ipsos: Monthly declaration of shares and voting rights - May 2025

Ipsos: Monthly declaration of shares and voting rights - May 2025 June 27, 2025 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF Date   Shares   Voting rights Theoretical* Exercisable** 31 May 2025 43,203,225 48,990,941 48,941,337 *This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch